Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021

• Главные авторы: Anthony Martinez (Автор), Tipu Khan (Автор), Douglas E. Dylla (Автор), John Marcinak (Автор), Michelle Collins (Автор), Brad Saget (Автор), Brian Conway (Автор)
• Формат: ‌
• Опубликовано: BMC, 2023-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Introduction Due to concerns over potential interactions between some hepatitis C direct-acting antivirals (DAAs) and opioids, we describe adverse event (AE) reports of concomitant use of opioids and DAAs. Methods AEs reported (July 28, 2017-December 31, 2021) with the administration of the...